年轻成年人勃起功能障碍:叙事审查
Ali Safa1,2, Chady Waked3
1Urology, Hôtel-Dieu de France, Beirut, LBN.
Cureus
|August 14, 2025
概括
勃起功能障碍 (ED) 在年轻男性中正在上升,影响高达35%,并源于心理和有机原因. 综合管理包括改变生活方式,治疗和药物治疗.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 安德罗学与人类学
- 男人的健康 男人健康
背景情况:
- 勃起功能障碍 (ED) 在40岁以下的男性中越来越多地被诊断为勃起功能障碍.
- 从历史上看,ED被认为是一种主要影响老年男性的疾病.
- 心理学因素曾经被认为是年轻人群中ED的主要原因.
研究的目的:
- 审查年轻男性ED的流行病学.
- 在这个人口群体中探索ED的心理社会影响和病因因素.
- 综合目前对年轻男性ED的管理策略.
主要方法:
- 进行了对科学文献的叙事审查.
- 使用PubMed的搜索构建器,关键词是"勃起功能障碍"和"年轻".
- 确定了1981篇文章,根据相关性和质量进行了选择.
主要成果:
- 在年轻男性中,ED的患病率高达35%.
- 原因包括心理因素 (焦虑,抑郁) 和有机问题 (内皮功能障碍,荷尔蒙失衡,代谢综合征).
- 生活方式因素,如色情使用,睡眠不足,饮食,不运动和药物使用与ED有关.
结论:
- 年轻男性的ED是一种复杂,普遍的疾病,需要进行彻底的评估.
- 管理需要多学科的方法,结合药理和非药理干预措施.
- 需要进一步的研究,以提高这种不断增长的患者群体的治疗结果.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Male Sexual Response: Erection & Ejaculation
Sexual stimulation can take various forms, such as physical touch and visual or auditory cues. When this happens, the parasympathetic reflex in the sacral portion of the spinal cord is activated. This reflex stimulates the release of nitric oxide (NO), which then dilates the arterioles in the penis, increasing blood flow to the erectile tissues - the corpora cavernosa and corpus spongiosum.
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
The blood filling the erectile tissues compresses the veins, which helps to prevent blood from leaving...
Infertility in Males
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...


